Novartis Bioventures Ltd Insider Trading $ELDN Eledon Pharmaceuticals, Inc.
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in Eledon Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 4,493,458 shares
Current Value: $4,089,047
Latest Transaction: Jul 17 2015
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in Eledon Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.26 | 3,566 | 50,844 | 4,493,458 | 4.5 M to 4.5 M (-0.08 %) |
| Jul 15 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.41 | 27,861 | 401,477 | 4,497,024 | 4.5 M to 4.5 M (-0.62 %) |
| Jul 15 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 20,611 | 292,717 | 4,524,885 | 4.5 M to 4.5 M (-0.45 %) |
| Jun 18 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.27 | 1,120 | 15,982 | 4,545,496 | 4.5 M to 4.5 M (-0.02 %) |
| Jun 16 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 14,777 | 209,833 | 4,546,616 | 4.6 M to 4.5 M (-0.32 %) |
| Jun 16 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 5,919 | 84,050 | 4,561,393 | 4.6 M to 4.6 M (-0.13 %) |
| Jun 12 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 27,875 | 395,825 | 4,567,312 | 4.6 M to 4.6 M (-0.61 %) |
| Mar 20 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.50 | 46,141 | 669,045 | 4,595,187 | 4.6 M to 4.6 M (-0.99 %) |
| Mar 20 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.50 | 3,000 | 43,500 | 4,641,328 | 4.6 M to 4.6 M (-0.06 %) |
Page: 1